Company intelligence / Profile preview
Achelois BioPharma
Redwood City, California, United Statesachelois.bio ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Achelois BioPharma develops programmable immunotherapies using proprietary platforms to target complex human diseases. Their approach focuses on multivalent therapeutics designed to address multiple disease mechanisms simultaneously. No published clinical results as of the latest available information.[1][2][3]
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Multivalent therapeutics (including genetically engineered T cells and multivalent particles)Immunotherapy (GEM-T Cells)Genetically-programmed multivalent particles (MVPs)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
JLabs incubator program/investment partner[3]
Beyond the preview
Go deeper on Achelois BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Achelois BioPharma.